Acies Bio cost-competitive trans-zeatin
05.03.2023
Acies Bio makes trans-zeatin available at a cost competitive with that of chemical cytokinin analogs
In a quest to provide the next generation of agricultural inputs using natural and sustainable production methods, a leading European microbial biotech company Acies Bio developed a platform for production of natural cytokinins, as well as an efficient bioprocess for production of trans-zeatin, the most efficient natural cytokinin molecule. The process is based on one of Acies Bio’s highly efficient microbial platforms with GRAS/QPS status and is expected to lower the cost of trans-zeatin production up to a 100-fold compared to the current production methods. This break-through development opens an array of new possible commercial applications for this superior natural cytokinin.
Acies Bio's cytokinin platform has the potential to produce a wide variety of less studied cytokinins which may be shown to have multiple beneficial activities across many cash and row crops. Acies Bio is now working towards producing these new molecules to enable future studies of their complex effects on the physiology of different plants and envision future applications which are expected to play an important role in future sustainable farming practices, such as precision agriculture and regenerative agriculture. Ultimately, application of these next-generation plant growth regulators will lead to reduced use of chemical pesticides and fertilizers as well as healthier crops and soil.
In a quest to provide the next generation of agricultural inputs using natural and sustainable production methods, a leading European microbial biotech company Acies Bio developed a platform for production of natural cytokinins, as well as an efficient bioprocess for production of trans-zeatin, the most efficient natural cytokinin molecule. The process is based on one of Acies Bio’s highly efficient microbial platforms with GRAS/QPS status and is expected to lower the cost of trans-zeatin production up to a 100-fold compared to the current production methods. This break-through development opens an array of new possible commercial applications for this superior natural cytokinin.
Acies Bio's cytokinin platform has the potential to produce a wide variety of less studied cytokinins which may be shown to have multiple beneficial activities across many cash and row crops. Acies Bio is now working towards producing these new molecules to enable future studies of their complex effects on the physiology of different plants and envision future applications which are expected to play an important role in future sustainable farming practices, such as precision agriculture and regenerative agriculture. Ultimately, application of these next-generation plant growth regulators will lead to reduced use of chemical pesticides and fertilizers as well as healthier crops and soil.